NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
2-(4-{3-[(9Z)-2-(trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl}piperazin-1-yl)ethan-1-ol
|
2-(4-{3-[(9E)-2-(trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl}piperazin-1-yl)ethan-1-ol
|
2-(4-{3-[2-(trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl}piperazin-1-yl)ethan-1-ol
|
|
|
IUPAC Traditional name
|
α-flupenthixol
|
fluanxol
|
flupenthixol
|
|
|
Brand Name
|
Depixol
|
Emergil
|
Fluanxol
|
Fluanxol Depot
|
Flupentixol
|
Flurentixol
|
Fluxanxol
|
Siplaril
|
Siplarol
|
|
|
Synonyms
|
FX 703
|
(E/Z)-Flupentixol Dihydrochloride
|
4-[3-[(3Z)-2-(Trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl]-1-piperazineethanol Hydrochloride
|
α-Flupenthixol Hydrochloride
|
cis-Flupentixol Hydrochloride
|
Emergil
|
Fluanxol
|
Siplarol
|
Metamin
|
cis-(Z)-Flupentixol Dihydrochloride
|
4-[(3E)-3-[2-(Trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl]-1-piperazineethanol Hydrochloride (1:2)
|
trans-Flupentixol Hydrochloride
|
4-[3-[2-(Trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl]-1-piperazineethanol Dihydrochloride
|
β-Flupenthixol Dihydrochloride
|
trans-(E)-Flupentixol Dihydrochloride
|
Flupentixol
|
Flupenthixole
|
Flupenthixol
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
ATC CODE
|
|
CHEMBL
|
|
Chemspider ID
|
|
DrugBank ID
|
|
IUPHAR ligand ID
|
|
KEGG ID
|
|
Unique Ingredient Identifier
|
|
Wikipedia Title
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
Data Source
|
Data ID
|
Price
|
TRC
|
|
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
ALOGPS 2.1
Acid pKa
|
15.593099
|
H Acceptors
|
3
|
H Donor
|
1
|
LogD (pH = 5.5)
|
1.669585
|
LogD (pH = 7.4)
|
3.4309251
|
Log P
|
4.4967875
|
Molar Refractivity
|
128.1692 cm3
|
Polarizability
|
44.335587 Å3
|
Polar Surface Area
|
26.71 Å2
|
Rotatable Bonds
|
6
|
Lipinski's Rule of Five
|
true
|
Log P
|
4.56
|
LOG S
|
-5.04
|
Solubility (Water)
|
3.99e-03 g/l
|
DETAILS
DETAILS
DrugBank
Wikipedia
TRC
DrugBank -
DB00875
|
Item |
Information |
Drug Groups
|
approved |
Description
|
Flupentixol is an antipsychotic neuroleptic drug. It is a thioxanthene, and therefore closely related to the phenothiazines. Its primary use is as a long acting injection given two or three weekly to people with schizophrenia who have a poor compliance with medication and suffer frequent relapses of illness. It is a D1 and D2 receptor antagonist. |
Indication |
For use in the treatment of schizophrenia and depression |
Pharmacology |
Flupenthixol is an anxiolytic, antidepressive agent and a mood stabilizer. It inhibits the central monoamine receptors, particularly the dopamine D1 and D2 receptors. Therefore, it increases the amount of serotonin and noradrenaline that control mood and thinking, and improves mood. |
Toxicity |
LD50=300 mk/kg (Oral in mice); LD50=791 mg/kg (Oral in rats); LD50=87 mk/kg (IV in mice); LD50=37 mg/kg (IV in rats) |
Affected Organisms |
• |
Humans and other mammals |
|
Biotransformation |
Mainly hepatic |
Absorption |
Fairly slow and incomplete after oral administration |
Half Life |
19 to 39 hours |
Protein Binding |
Highly bound to plasma proteins (>95%) |
External Links |
|
|
REFERENCES
REFERENCES
From Suppliers
Google Scholar
PubMed
Google Books
- • Nielsen, et al.: Acta Pharmacol. Toxicol., 32, 363 (1973)
- • Post, M.L., et al.: Nature, 256, 342 (1973)
- • Peuch, et al.: Neuropharmacology, 20, 1279 (1973)
- • Nielsen, et al.: Acta Pharmacol. Toxicol., 32, 363 (1973)
- • Post, M.L., et al.: Nature, 256, 342 (1973)
- • Peuch, et al.: Neuropharmacology, 20, 1279 (1973)
- • Li Wan Po, A., et al.: J. Pharm. Pharmacol., 32, 25 (1980)
- • Waddington, J., et al.: Eur. J. Pharmacol., 69, 511 (1980)
- • Kula, N., et al.: Cell. Mol. Neurobiol., 14, 185 (1980)
- Searching...Please wait...
PATENTS
PATENTS
PubChem Patent
Google Patent